icometrix's MRI measures for people with Multiple Sclerosis receive Medtech Innovation briefing from the National Institute for Health and Care Evidence (NICE)
LONDON, April 21, 2022 /PRNewswire/ -- icometrix, the worldwide leader in digital health technology solutions for neurological conditions, announced the recent release of a Medtech Innovation Briefing (MIB) [MIB291] from the internationally renowned NICE for the CE markers and FDA cleared icobrain MRI measures in Multiple Sclerosis (MS).